MIG1 regulates resistance of Candida albicans against the fungistatic effect of weak organic acids

Eukaryotic Cell

Volumn 14, Issue 10, 2015, Pages 1054-1061

  Cottier, Fabien ^a   Tan, Alrina Shin Min ^a   Xu, Xiaoli ^b   Wang, Yue ^b   Pavelka, Norman ^a  

^a AGENCY FOR SCIENCE   (Singapore)

^b INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ANTIFUNGAL AGENT; BUTYRIC ACID; FUNGAL PROTEIN; LACTIC ACID; PROPIONIC ACID; PROPIONIC ACID DERIVATIVE; REPRESSOR PROTEIN;

ANTIFUNGAL RESISTANCE; CANDIDA ALBICANS; CANDIDIASIS; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ACETIC ACID; ANTIFUNGAL AGENTS; BUTYRIC ACID; CANDIDA ALBICANS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; FUNGAL PROTEINS; LACTIC ACID; MICROBIAL SENSITIVITY TESTS; PROPIONATES; REPRESSOR PROTEINS;

EID: 84942885774     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00129-15     Document Type: Article

References (51)

1. Pfaller MA, Diekema DJ. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20:133–163. http://dx.doi.org/10.1128/CMR.00029-06
2. MacCallum DM. 2010. Candida infections and modelling disease, p 41– 67. In Ashbee R, Bignell EM (ed), Pathogenic yeasts. Springer, Berlin, Germany.
3. Miranda LN, van der Heijden IM, Costa SF, Sousa AP, Sienra RA, Gobara S, Santos CR, Lobo RD, Pessoa VP, Jr, Levin AS. 2009. Candida colonisation as a source for candidaemia. J Hosp Infect 72:9–16. http://dx.doi.org/10.1016/j.jhin.2009.02.009
4. Dethlefsen L, Huse S, Sogin ML, Relman DA. 2008. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6:e280. http://dx.doi.org/10.1371/journal.pbio.0060280
5. Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, Young VB. 2009. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 77: 2367–2375. http://dx.doi.org/10.1128/IAI.01520-08
6. Pirotta MV, Garland SM. 2006. Genital Candida species detected in samples from women in Melbourne, Australia, before and after treatment with antibiotics. J Clin Microbiol 44:3213–3217. http://dx.doi.org/10.1128/JCM.00218-06
7. Swinne D, Nolard N, Van Rooij P, Detandt M. 2009. Bloodstream yeast infections: a 15-month survey. Epidemiol Infect 137:1037–1040. http://dx.doi.org/10.1017/S0950268808001763
8. Naglik JR, Fidel PL, Jr, Odds FC. 2008. Animal models of mucosal Candida infection. FEMS Microbiol Lett 283:129–139. http://dx.doi.org/10.1111/j.1574-6968.2008.01160.x.
9. Ekenna O, Sherertz RJ. 1987. Factors affecting colonization and dissemination of Candida albicans from the gastrointestinal tract of mice. Infect Immun 55:1558–1563
10. Koh AY, Kohler JR, Coggshall KT, Van Rooijen N, Pier GB. 2008. Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS Pathog 4:e35. http://dx.doi.org/10.1371/journal.ppat.0040035
11. Balish E, Filutowicz H, Oberley TD. 1990. Correlates of cell-mediated immunity in Candida albicans-colonized gnotobiotic mice. Infect Immun 58:107–113
12. Pope LM, Cole GT, Guentzel MN, Berry LJ. 1979. Systemic and gastrointestinal candidiasis of infant mice after intragastric challenge. Infect Immun 25:702–707
13. Cole GT, Lynn KT, Seshan KR, Pope LM. 1989. Gastrointestinal and systemic candidosis in immunocompromised mice. J Med Vet Mycol 27: 363–380. http://dx.doi.org/10.1080/02681218980000491
14. Hasegawa M, Osaka T, Tawaratsumida K, Yamazaki T, Tada H, Chen GY, Tsuneda S, Nunez G, Inohara N. 2010. Transitions in oral and intestinal microflora composition and innate immune receptordependent stimulation during mouse development. Infect Immun 78: 639–650. http://dx.doi.org/10.1128/IAI.01043-09
15. Yamaguchi N, Sonoyama K, Kikuchi H, Nagura T, Aritsuka T, Kawabata J. 2005. Gastric colonization of Candida albicans differs in mice fed commercial and purified diets. J Nutr 135:109–115
16. Mortensen PB, Clausen MR. 1996. Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol Suppl 216:132–148
17. Cribby S, Taylor M, Reid G. 2008. Vaginal microbiota and the use of probiotics. Interdiscip Perspect Infect Dis 2008:256490. http://dx.doi.org/10.1155/2008/256490
18. O’Hanlon DE, Moench TR, Cone RA. 2011. In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide. BMC Infect Dis 11:200. http://dx.doi.org/10.1186/1471-2334-11-200
19. Topping DL, Clifton PM. 2001. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 81:1031–1064
20. Nugent SG, Kumar D, Rampton DS, Evans DF. 2001. Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs. Gut 48:571–577. http://dx.doi.org/10.1136/gut.48.4.571
21. Huang CB, Alimova Y, Myers TM, Ebersole JL. 2011. Short- and medium- chain fatty acids exhibit antimicrobial activity for oral microorganisms. Arch Oral Biol 56:650–654. http://dx.doi.org/10.1016/j.archoralbio.2011.01.011
22. Kohler GA, Assefa S, Reid G. 2012. Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans. Infect Dis Obstet Gynecol 2012: 636474. http://dx.doi.org/10.1155/2012/636474
23. Osset J, Garcia E, Bartolome RM, Andreu A. 2001. Role of Lactobacillus as protector against vaginal candidiasis. Med Clin (Barc) 117:285–288. (In Spanish.) http://dx.doi.org/10.1016/S00257753(01)720891
24. De Man JC, Rogosa M, Sharpe ME. 1960. A medium for the cultivation of lactobacilli. J Appl Bacteriol 23:130–135. http://dx.doi.org/10.1111/j.1365-2672.1960.tb00188.x.25.
25. Kikuchi H, Yajima T. 1992. Correlation between water-holding capacity of different types of cellulose in vitro and gastrointestinal retention time in vivo of rats. J Sci Food Agric 60:139–146. http://dx.doi.org/10.1002/jsfa.2740600202
26. Homann OR, Dea J, Noble SM, Johnson AD. 2009. A phenotypic profile of the Candida albicans regulatory network. PLoS Genet 5:e1000783. http://dx.doi.org/10.1371/journal.pgen.1000783
27. Ohman H, Vahlquist A. 1994. In vivo studies concerning a pH gradient in human stratum corneum and upper epidermis. Acta Derm Venereol 74: 375–379
28. Cottier F, Tan AS, Chen J, Lum J, Zolezzi F, Poidinger M, Pavelka N. 2015. The transcriptional stress response of Candida albicans to weak organic acids. G3 (Bethesda) 5:497–505. http://dx.doi.org/10.1534/g3.114.015941
29. Maccallum DM. 2012. Hosting infection: experimental models to assay Candida virulence. Int J Microbiol 2012:363764. http://dx.doi.org/10.1155/2012/363764
30. Davis D, Wilson RB, Mitchell AP. 2000. RIM101-dependent andindependent pathways governpHresponses in Candida albicans. Mol Cell Biol 20:971–978. http://dx.doi.org/10.1128/MCB.20.3.971-978.2000
31. Noverr MC, Huffnagle GB. 2004. Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect Immun 72:6206–6210. http://dx.doi.org/10.1128/IAI.72.11.6206-6210.2004
32. Cottier F, Muhlschlegel FA. 2009. Sensing the environment: response of Candida albicans to the X factor. FEMS Microbiol Lett 295:1–9. http://dx.doi.org/10.1111/j.1574-6968.2009.01564.x.
33. Khamooshi K, Sikorski P, Sun N, Calderone R, Li D. 2014. The Rbf1, Hfl1 and Dbp4 of Candida albicans regulate common as well as transcrip-tion factor-specific mitochondrial and other cell activities. BMC Genomics 15:56. http://dx.doi.org/10.1186/1471-2164-15-56
34. Murad AM, Leng P, Straffon M, Wishart J, Macaskill S, MacCallum D, Schnell N, Talibi D, Marechal D, Tekaia F, d’Enfert C, Gaillardin C, Odds FC, Brown AJ. 2001. NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans. EMBO J 20: 4742–4752. http://dx.doi.org/10.1093/emboj/20.17.4742
35. Braun BR, Johnson AD. 1997. Control of filament formation in Candida albicans by the transcriptional repressor TUP1. Science 277:105–109. http://dx.doi.org/10.1126/science.277.5322.105
36. Sasse C, Morschhauser J. 2012. Gene deletion in Candida albicans wildtype strains using the SAT1-flipping strategy. Methods Mol Biol 845:3–17. http://dx.doi.org/10.1007/978-1-61779-539-8_1
37. Nehlin JO, Ronne H. 1990. Yeast MIG1 repressor is related to the mammalian early growth response and Wilms’ tumour finger proteins. EMBO J 9:2891–2898
38. Ben-Ami R, Olshtain-Pops K, Krieger M, Oren I, Bishara J, Dan M, Wiener-Well Y, Weinberger M, Zimhony O, Chowers M, Weber G, Potasman I, Chazan B, Kassis I, Shalit I, Block C, Keller N, Kontoyiannis DP, Giladi M. 2012. Antibiotic exposure as a risk factor for fluconazole- resistant Candida bloodstream infection. Antimicrob Agents Chemother 56:2518–2523. http://dx.doi.org/10.1128/AAC.05947-11
39. Ramsdale M, Selway L, Stead D, Walker J, Yin Z, Nicholls SM, Crowe J, Sheils EM, Brown AJ. 2008. MNL1 regulates weak acid-induced stress responses of the fungal pathogen Candida albicans. Mol Biol Cell 19: 4393–4403. http://dx.doi.org/10.1091/mbc.E07-09-0946
40. Cottier F, Pavelka N. 2012. Complexity and dynamics of host-fungal interactions. Immunol Res 53:127–135. http://dx.doi.org/10.1007/s12026-012-8265-y.
41. Kren A, Mamnun YM, Bauer BE, Schuller C, Wolfger H, Hatzixanthis K, Mollapour M, Gregori C, Piper P, Kuchler K. 2003. War1p, a novel transcription factor controlling weak acid stress response in yeast. Mol Cell Biol 23:1775–1785. http://dx.doi.org/10.1128/MCB.23.5.1775-1785.2003
42. Murad AM, d’Enfert C, Gaillardin C, Tournu H, Tekaia F, Talibi D, Marechal D, Marchais V, Cottin J, Brown AJ. 2001. Transcript profiling in Candida albicans reveals new cellular functions for the transcriptional repressors CaTup1, CaMig1 and CaNrg1. Mol Microbiol 42:981–993. http://dx.doi.org/10.1046/j.1365-2958.2001.02713.x.
43. Klein CJ, Olsson L, Nielsen J. 1998. Glucose control in Saccharomyces cerevisiae: the role of Mig1 in metabolic functions. Microbiology 144(Pt 1):13–24. http://dx.doi.org/10.1099/00221287-144-1-13
44. Zaragoza O, Rodriguez C, Gancedo C. 2000. Isolation of the MIG1 gene from Candida albicans and effects of its disruption on catabolite repression. J Bacteriol 182:320–326. http://dx.doi.org/10.1128/JB.182.2.320-326.2000
45. Treitel MA, Carlson M. 1995. Repression by SSN6-TUP1 is directed by MIG1, a repressor/activator protein. Proc Natl Acad Sci U S A 92:3132–3136. http://dx.doi.org/10.1073/pnas.92.8.3132
46. Piper P, Mahe Y, Thompson S, Pandjaitan R, Holyoak C, Egner R, Muhlbauer M, Coote P, Kuchler K. 1998. The pdr12 ABC transporter is required for the development of weak organic acid resistance in yeast. EMBO J 17:4257–4265. http://dx.doi.org/10.1093/emboj/17.15.4257
47. Alexandre H, Mathieu B, Charpentier C. 1996. Alteration in membrane fluidity and lipid composition, and modulation of H(+)-ATPase activity in Saccharomyces cerevisiae caused by decanoic acid. Microbiology 142(Pt 3):469–475. http://dx.doi.org/10.1099/13500872-142-3-469
48. Rodaki A, Bohovych IM, Enjalbert B, Young T, Odds FC, Gow NA, Brown AJ. 2009. Glucose promotes stress resistance in the fungal pathogen Candida albicans. Mol Biol Cell 20:4845–4855. http://dx.doi.org/10.1091/mbc.E09-01-0002
49. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, Rodloff A, Fu W, Ling TA. 2010. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol 48:1366–1377. http://dx.doi.org/10.1128/JCM.02117-09
50. Vicariotto F, Del Piano M, Mogna L, Mogna G. 2012. Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study. J Clin Gastroenterol 46(Suppl):S73–S80. http://dx.doi.org/10.1097/MCG.0b013e3182684d71
51. Rohlke F, Stollman N. 2012. Fecal microbiota transplantation in relapsing Clostridium difficile infection. Therap Adv Gastroenterol 5:403–420. http://dx.doi.org/10.1177/1756283X12453637.